基于变分自编码器的深度学习与影像组学预测局部晚期食管鳞状细胞癌新辅助化疗免疫治疗后病理完全缓解
本研究纳入253例接受新辅助化疗免疫治疗并行动脉期增强CT的局部晚期食管鳞状细胞癌患者构建训练队列,采用变分自编码器深度学习与影像组学建立DL和DLR模型,另招募40例作为测试队列。DLR模型在验证队列和测试队列的AUC分别为0.949和0.926,均优于DL模型的0.935和0.839。
要点
- DLR模型在测试队列预测pCR的AUC为0.926,优于DL模型的0.839。
- DLR模型在测试队列的F1分数为0.836,高于DL模型的0.727。
- 预测pCR需基于新辅助化疗免疫治疗前增强CT图像构建模型。
核心结论
- 基于变分自编码器的深度学习与影像组学构建的DLR模型可预测局部晚期食管鳞状细胞癌患者新辅助化疗免疫治疗后的病理完全缓解,且性能优于单纯DL模型。
研究设计与样本
- 研究论文;训练队列253例于2019年7月至2023年7月在本院接受新辅助化疗免疫治疗并行动脉期增强CT的局部晚期食管鳞状细胞癌患者,测试队列40例于2023年8月至2024年8月在本机构招募;采用五折交叉验证训练和验证模型;参考标准为病理完全缓解。
诊断标准与关键数值
- 验证队列DL模型AUC为0.935(95% CI: 0.786-0.992),DLR模型AUC为0.949(95% CI: 0.910-0.986)。
- 测试队列DL模型AUC为0.839(95% CI: 0.726-0.853),DLR模型AUC为0.926(95% CI: 0.886-0.934)。
- 验证队列DL模型F1分数为0.726(95% CI: 0.476-0.842),DLR模型F1分数为0.766(95% CI: 0.625-0.842)。
- 测试队列DL模型F1分数为0.727(95% CI: 0.645-0.811),DLR模型F1分数为0.836(95% CI: 0.820-0.850)。
- DLR模型的精确率与召回率之间的性能差距小于DL模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Neoadjuvant chemoimmunotherapy (nCIT) is gradually becoming an important treatment strategy for patients with locally advanced oesophageal squamous cell carcinoma (LA-OSCC). This study aimed to predict the pathological complete response (pCR) of these patients using variational autoencoder (VAE)-based deep learning and radiomics technology.
METHODS: A total of 253 LA-ESCC patients who were treated with nCIT and underwent enhanced CT at our hospital between July 2019 and July 2023 were included in the training cohort. VAE-based deep learning and radiomics were utilized to construct deep learning (DL) models and deep learning radiomics (DLR) models. The models were trained and validated via fivefold cross-validation among 253 patients. Forty patients were recruited from our institution between August 2023 and August 2024 as the test cohort.
RESULTS: The AUCs of the DL and DLR models were 0.935 (95% CI: 0.786-0.992) and 0.949 (95% CI: 0.910-0.986) in the validation cohort and 0.839 (95% CI: 0.726-0.853) and 0.926 (95% CI: 0.886-0.934) in the test cohort. The performance gap between Precision and Recall of the DLR model was smaller than that of the DL model. The F1 scores of the DL and DLR models were 0.726 (95% confidence interval [CI]: 0.476-0.842) and 0.766 (95% CI: 0.625-0.842) in the validation cohort and 0.727 (95% CI: 0.645-0.811) and 0.836 (95% CI: 0.820-0.850) in the test cohort.
CONCLUSIONS: We constructed a DLR model to predict pCR in nCIT-treated LA-ESCC patients, which demonstrated superior performance compared to the DL model.
ADVANCES IN KNOWLEDGE: We innovatively used VAE-based deep learning and radiomics to construct the DLR model for predicting pCR of LA-ESCC after nCIT.
引用
- Gu Q, Chen S, Dekker A, et al. Variational autoencoder-based deep learning and radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced oesophageal squamous cell carcinoma. Br J Radiol. 2026. PMID: 40996309. doi:10.1093/bjr/tqaf239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。